https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Retinopathy prediction in type 2 diabetes: Time-varying Cox proportional hazards and machine learning models https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54491 Wed 28 Feb 2024 16:25:16 AEDT ]]> The association between genetic polymorphisms in ABCG2 and SLC2A9 and urate: an updated systematic review and meta-analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38721 Wed 19 Jan 2022 09:36:02 AEDT ]]> Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51602 Tue 12 Sep 2023 13:35:14 AEST ]]> An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50654 Tue 01 Aug 2023 12:10:37 AEST ]]> Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52121 Thu 28 Sep 2023 15:03:25 AEST ]]> Causal associations of urate with cardiovascular risk factors: two-sample Mendelian Randomization https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42787 ABCG2, SLC2A9, SLC17A1, SLC22A11, and SLC22A12 showed consistent causal effects of urate on HDL-C from all methods with 0.038 to 0.057 SD decrease in HDL-C per 1 mg/dl increase of urate, and no evidence of horizontal pleiotropy was detected. Conclusion: Our study suggests a significant and robust causal effect of genetically predicted urate on HDL-C. This finding may explain a small proportion (7%) of the association between increased urate and cardiovascular disease but points to urate being a novel cardiac risk factor.]]> Fri 02 Sep 2022 14:02:17 AEST ]]>